Blood Protein Test Reveals Which Organs Age Fastest and Who Lives Longest

Biological aging does not proceed uniformly across the body—different organs deteriorate at different rates, and identifying which organs matter most for health and longevity has been a major challenge. This large-scale study from Stanford University addresses that gap by applying plasma proteomics to estimate the biological age of 11 major organs in 44,498 adults from the UK Biobank, using the Olink platform measuring approximately 2,916 proteins.

The research team first identified proteins enriched in specific organs using GTEx RNA-sequencing data, then trained machine learning (LASSO) models to predict chronological age from those organ-specific protein levels. The resulting 'organ age gap'—the difference between predicted and actual age—served as a measure of relative biological age. Organ age gaps were only weakly correlated with one another (mean r = 0.21), confirming that organs age independently. Longitudinal analyses in a subset of 1,176 individuals showed moderate-to-strong stability of these estimates over approximately 9 years (mean r = 0.6).

Key disease association findings were striking. An accelerated brain age (top ~7% of population) conferred a hazard ratio of 3.1 for future Alzheimer's disease onset—comparable to carrying one copy of APOE4, the strongest known genetic risk factor. Conversely, a youthful brain (HR = 0.26) was protective at a level similar to carrying two APOE2 copies, and this was independent of actual APOE genotype. Other organs showed organ-specific disease associations: aged hearts predicted heart failure, aged lungs predicted COPD, aged kidneys predicted chronic kidney disease, and aged pancreases predicted type 2 diabetes.

For mortality, the accumulation of aged organs was strongly dose-dependent: 2–4 aged organs raised mortality risk 2.3-fold, 5–7 aged organs 4.5-fold, and 8 or more aged organs 8.3-fold. Uniquely among all 11 organs, only youthful brains (HR = 0.60) and youthful immune systems (HR = 0.58) were independently associated with reduced mortality and longevity. Individuals with both a youthful brain and immune system had a 44% lower mortality risk (HR = 0.44). This pattern held after adjusting for established biomarkers including PhenoAge and eGFR.

Organ age gaps were also modifiable: lifestyle factors (exercise, diet, smoking, alcohol), socioeconomic status, and certain medications were all associated with organ age. This suggests these proteomic biomarkers could serve as responsive monitoring tools for longevity interventions. The study points to the brain and immune system as priority targets for anti-aging strategies, while acknowledging that the UK Biobank's age range (40–70 years) and predominantly European ancestry limit generalizability.